Michael A. Metzger, President and COO at Syndax Pharmaceuticals Inc (SNDX), sold 108,106 shares at $19.08 ($2.1M) on 2021-12-16, disclosed to the SEC on 2021-12-20.
Open-market sale of $2.1M SNDX by President and COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.08 | 22,715 | $433K | 20.3% |
| 2 | $19.08 | 22,715 | $433K | 20.3% |
| 3 | $19.02 | 1,676 | $32K | 1.5% |
| 4 | $20.29 | 16,000 | $325K | 15.2% |
| 5 | $20.29 | 45,000 | $913K | 42.7% |
| Total | $19.76 avg | 108,106 |
| $2.1M |
| 100% |
| Filing → |
| SNDX | SELL | 2026-02-10 | $361K | — | Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |